Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx for $28 each was expected have a value of $1.9 billion net of estimated cash required. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved….

Thousands of buyers have made complaints about how much they were charged for financing.

Workers went on strike Monday at the Michigan plant where Dodge parent company Stellantis produces its highly profitable Ram 1500 series pickup truck, according to the United Auto Workers union. The walkout at the Sterling Heights Assembly plant marks another significant escalation in the UAW’s concurrent strikes against the “Big Three” automakers, which includes Ford…

As environmental concerns become increasingly urgent, businesses are under growing pressure to adopt sustainable practices. In 2024, sustainability is not just a buzzword but a crucial component of strategic planning and operational efficiency. By implementing sustainable practices, companies can reduce their environmental footprint, enhance their brand reputation, and drive long-term growth. This blog post explores…

In his first week in office, President Joe Biden has reimposed a host of COVID-19 travel restrictions, while also repealing Donald Trump’s discriminatory Muslim ban. The actions mean the US will now start allowing visitors from predominantly Muslim and African countries who were previously restricted from entering the US under Trump. At the same time,…

To repurpose an old joke: How do you create a $15-billion company? Answer: First, start with a $44-billion company … Yes, we’re talking about Elon Musk and the fate of Twitter-now-X, the social media platform he bought in October 2022 and spent the subsequent year turning into a hive of antisemitism, racism and all other…